Home
Reels
Grupuri
Pagini
Arata mai mult
Grupuri Pagini Events Blogs Funding
Conecteaza-te Inscrie-te
Night Mode
How Are Disease-Modifying Biologics Transforming Pulmonary Arterial Hypertension Treatment?
For decades, PAH treatment relied on vasodilators that managed symptoms but did not address the underlying disease process. Disease-modifying biologics are transforming PAH treatment by targeting the vascular remodeling that drives disease progression, offering the potential for improved long-term outcomes. This innovation is a major driver of growth in the Pulmonary Arterial Hypertension...
0 Commentarii ·0 Distribuiri ·135 Views ·0 previzualizare
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!